(Q46107681)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Daniel Hartmann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Arndt Weinmann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Ulrike Protzer

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

11

Helmut Friess

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

2

Florian Reisinger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Martin Franz Sprinzl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Andreas Puschnik

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Kerstin Ackermann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Matthias Schiemann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Peter Robert Galle

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Marcus Schuchmann

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Gerd Otto

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Mathias Heikenwalder

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

2358-2368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

Tumour-educated macrophages promote tumour progression and metastasis

24 February 2020

cites work

1 reference

Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients

21 January 2018

1 reference

Altered macrophage differentiation and immune dysfunction in tumor development

21 January 2018

1 reference

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

21 January 2018

1 reference

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

21 January 2018

1 reference

The kinase inhibitors sunitinib and sorafenib differentially affect NK cell antitumor reactivity in vitro

21 January 2018

1 reference

The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE₂ in murine macrophages

21 January 2018

1 reference

Transgenic expression of entire hepatitis B virus in mice induces hepatocarcinogenesis independent of chronic liver injury

21 January 2018

1 reference

A lymphotoxin-driven pathway to hepatocellular carcinoma

21 January 2018

1 reference

Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice

21 January 2018

1 reference

TLR-dependent cross talk between human Kupffer cells and NK cells

21 January 2018

1 reference

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

21 January 2018

1 reference

Interactions between human NK cells and macrophages in response to Salmonella infection.

21 January 2018

1 reference

The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes

21 January 2018

1 reference

Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.

21 January 2018

1 reference

"Re-educating" tumor-associated macrophages by targeting NF-kappaB.

21 January 2018

1 reference

Characterization of kinase inhibitors using different phosphorylation states of colony stimulating factor-1 receptor tyrosine kinase.

21 January 2018

1 reference

Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.

21 January 2018

1 reference

The regulation of Th1 responses by the p38 MAPK

21 January 2018

1 reference

M-CSF elevates c-Fos and phospho-C/EBPalpha(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification

21 January 2018

1 reference

Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment

21 January 2018

1 reference

High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid.

21 January 2018

1 reference

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

21 January 2018

1 reference

Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis.

21 January 2018

1 reference

Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents

21 January 2018

1 reference

STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.

21 January 2018

1 reference

TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.

21 January 2018

1 reference

Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation

21 January 2018

1 reference

Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression

21 January 2018

1 reference

IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins.

21 January 2018

1 reference

p50 Nuclear Factor- B Overexpression in Tumor-Associated Macrophages Inhibits M1 Inflammatory Responses and Antitumor Resistance

21 January 2018

1 reference

High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma

21 January 2018

1 reference

7 January 2021

Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients

1 reference

7 January 2021

Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy

1 reference

7 January 2021

Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation

1 reference

7 January 2021

Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression

1 reference

7 January 2021

Production of IL-1 and its receptor antagonist is regulated differently by IFN-gamma and IL-4 in human monocytes and alveolar macrophages

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23424039%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference